Literature DB >> 31396686

Measuring inflammation in rheumatoid arthritis with a new clinical and ultrasound index: development and initial validation.

Juan José de Agustín1, Alba Erra2, Andrés Ponce3, Carmen Moragues4,5, Cesar Díaz-Torné5, Delia Reina6, Estefanía Moreno7, Julio Ramírez8, Lourdes Mateo9, Manel Pujol Busquets10, Patricia Moya5, Pilar Santo-Panero11, Sergi Ros-Expósito12, Javier Narváez13, Raimon Sanmartí8, Mª Jesús García de Yébenes14, Loreto Carmona14.   

Abstract

With the aim to develop and validate a clinical + ultrasound (US) inflammation score in rheumatoid arthritis (RA) for use in clinical practice, a mixed-method study was conducted. The theoretical development of the index was achieved with qualitative methodology (discussion group and Delphi survey). Subsequently, a cross-sectional study was carried out to analyse issues related to scoring and validation of the new index. RA patients underwent clinical [28 swollen and tender joints count, patient and physician global assessment (PhGA), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP)], and US assessments [synovitis or tenosynovitis by grey-scale (GS) and power Doppler (PD) of 42 structures]. An index was created based on statistical models and expert interaction. Construct validity was tested by correlation with DAS28, SDAI, CDAI, and PhGA. Reliability was evaluated in a subgroup of patients with the intraclass correlation coefficient (ICC). US assessment, CRP, and swollen joints were the items that passed the prioritization phase (Delphi study). For the cross-sectional study, 281 patients were randomly divided into design (n = 141) and validation samples (n = 140). The combination of US sites chosen (7 bilaterally) detected the maximum proportion of synovitis and PD present. Three scoring methods were tested: semiquantitative (0-3 GS + 0-3 PD), dichotomous (0/1 GS + 0/1 PD), and qualitative (0/1 based on algorithm). All showed strong correlation with activity measures (ρ ≥ 0.60), and reliability (ICC 0.89-0.93). The index with best parameters of validity, feasibility, and reliability was the qualitative. The final index chosen was the sum of swollen joint count, US qualitative score, and CRP. The UltraSound Activity score is a valid and reliable measure of inflammation in RA equal to the sum of 28 SJC, a simplified (0/1) US assessment of 11 structures and CRP. It is necessary further investigation to demonstrate additional value over existing indices.

Entities:  

Keywords:  Composite score; Index; Rheumatoid arthritis; Ultrasound; Validation studies

Mesh:

Year:  2019        PMID: 31396686     DOI: 10.1007/s00296-019-04383-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  41 in total

Review 1.  A systematic literature review of US definitions, scoring systems and validity according to the OMERACT filter for tendon lesion in RA and other inflammatory joint diseases.

Authors:  María Alcalde; Maria Antonietta D'Agostino; George A W Bruyn; Ingrid Möller; Annamaria Iagnocco; Richard J Wakefield; Esperanza Naredo
Journal:  Rheumatology (Oxford)       Date:  2012-02-29       Impact factor: 7.580

2.  Development and evaluation of a novel ultrasound score for large joints in rheumatoid arthritis: one year of experience in daily clinical practice.

Authors:  Wolfgang Hartung; Herbert Kellner; Johannes Strunk; Horst Sattler; Wolfgang A Schmidt; Boris Ehrenstein; Martin Fleck; Marina Backhaus
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-05       Impact factor: 4.794

3.  Development of a disease activity score based on judgment in clinical practice by rheumatologists.

Authors:  D M van der Heijde; M van 't Hof; P L van Riel; L B van de Putte
Journal:  J Rheumatol       Date:  1993-03       Impact factor: 4.666

4.  Outcome measures in rheumatoid arthritis clinical trials: assessing improvement.

Authors:  J R Kirwan
Journal:  J Rheumatol       Date:  1993-03       Impact factor: 4.666

5.  A reduced 12-joint ultrasound examination predicts lack of X-ray progression better than clinical remission criteria in patients with rheumatoid arthritis.

Authors:  Eugenio de Miguel; Angela Pecondón-Español; Manuel Castaño-Sánchez; Alfonso Corrales; Ricardo Gutierrez-Polo; Manuel Rodriguez-Gomez; Jose A Pinto-Tasende; Jose L Rivas; José Ivorra-Cortés
Journal:  Rheumatol Int       Date:  2017-04-07       Impact factor: 2.631

6.  A simplified disease activity index for rheumatoid arthritis for use in clinical practice.

Authors:  J S Smolen; F C Breedveld; M H Schiff; J R Kalden; P Emery; G Eberl; P L van Riel; P Tugwell
Journal:  Rheumatology (Oxford)       Date:  2003-02       Impact factor: 7.580

Review 7.  Advances in sonographic scoring of rheumatoid arthritis.

Authors:  Sarah Ohrndorf; Marina Backhaus
Journal:  Ann Rheum Dis       Date:  2012-12-19       Impact factor: 19.103

8.  Accuracy of ultrasound for the diagnosis of cervical lymph node metastasis in esophageal cancer: a systematic review and meta-analysis.

Authors:  Xue-Feng Leng; Yi Zhu; Ge-Ping Wang; Jian Jin; Lei Xian; Yu-Hong Zhang
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

9.  Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.

Authors:  Toshihiro Matsui; Yoshiaki Kuga; Atsushi Kaneko; Jinju Nishino; Yoshito Eto; Noriyuki Chiba; Masayuki Yasuda; Koichiro Saisho; Kota Shimada; Shigeto Tohma
Journal:  Ann Rheum Dis       Date:  2007-03-16       Impact factor: 19.103

10.  Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study.

Authors:  Maria-Antonietta D'Agostino; Richard J Wakefield; Hilde Berner-Hammer; Olivier Vittecoq; Georgios Filippou; Peter Balint; Ingrid Möller; Annamaria Iagnocco; Esperanza Naredo; Mikkel Østergaard; Maarten Boers; Corine Gaillez; Karina Van Holder; Manuela Le Bars
Journal:  Ann Rheum Dis       Date:  2015-11-20       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.